1.Felsenfeld, O (1971) Borrelia: Strains, Vectors, Human and Animal Borreliosis. St. Louis, Missouri, USA: Green, 180.
2.Cutler, SJ et al. (1997) Borrelia recurrentis characterization and comparison with relapsing-fever, Lyme-associated, and other Borrelia spp. International Journal of Systematic Bacteriology 47, 958–968.
3.Larsson, C et al. (2009) A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice. PLoS Neglected Tropical Diseases 3, e522.
4.Cutler, SJ et al. (1994) Successful in-vitro cultivation of Borrelia recurrentis. Lancet 343, 242.
5.Marosevic, D et al. (2017) First insights in the variability of Borrelia recurrentis genomes. PLoS Neglected Tropical Diseases 11, e0005865.
6.Ružić-Sabljić, E et al. (2017) Comparison of MKP and BSK-H media for the cultivation and isolation of Borrelia burgdorferi sensu lato. PLoS ONE 12, e0171622.
7.Lescot, M et al. (2008) The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genetics 4, e1000185.
8.Elbir, H et al. (2014) African relapsing fever Borreliae genomospecies revealed by comparative genomics. Frontiers in Public Health. 2, 43.
9.Amanzougaghene, N et al. (2016) Head lice of pygmies reveal the presence of relapsing fever Borreliae in the Republic of Congo. PLoS Neglected Tropical Diseases 10, e0005142.
10.Sholdt, LL, Holloway, ML and Fronk, WD. The epidemiology of human pediculosis in Ethiopia. Special Publication, Navy Disease Vector Ecology and Control Center, Naval Air Station, Jacksonville, Florida 32212 (Fig. 26, page 76), pp. 159.
11.Sangaré, AK, Doumbo, OK and Raoult, D (2016) Management and treatment of human lice. Biomed Research International 2016, 8962685.
12.Bryceson, ADM et al. (1970) Louse-borne relapsing fever. A clinical and laboratory study of 62 cases in Ethiopia and a reconsideration of the literature. Quarterly Journal of Medicine 39, 129–170.
13.Larsson, C et al. (2006) Complications of pregnancy and transplacental transmission of relapsing-fever borreliosis. Journal of Infectious Diseases 194, 1367–1374.
14.Fuchs, PC and Oyama, AA (1969) Neonatal relapsing fever due to transplacental transmission of Borrelia. Journal of the American Medical Association 208, 690–692.
15.Lloyd, GER (ed). (1983) Hippocratic Writings (Translated by Chadwick J and Mann WN). London: Penguin Books, 95–98.
16.MacArthur, W (1957) Historical notes on some epidemic diseases associated with jaundice. British Medical Bulletin 13, 146–149.
17.Guellil, M et al. (2018) Genomic blueprint of a relapsing fever pathogen in 15th century Scandinavia. Proceedings of the National Academy of Sciences U S A 115, 10422–10427.
18.Rutty, J (1770) A Chronological History of the Weather and Seasons, and of the Prevailing Diseases in Dublin. London: Robinson and Roberts.
19.Craigie, D (1843) Notice of a febrile disorder which has prevailed at Edinburgh during the Summer of 1843. Edinburgh Medical and Surgical Journal 60, 410–418.
20.Henderson, W (1844) On some of the characters which distinguish the fever at present epidemic from typhus. Edinburgh Medical and Surgical Journal 61, 201–225.
21.Murchison, C (1862) A Treatise on the Continued Fevers of Great Britain. London, Parker, and Bourn, 290–409.
22.Wright, DJ and Maria, B (2011) Ich bin ein Berliner. The contributions of early British colonial and German scientists to the elucidation of the nature of spirochaetes. Clinical Microbiology and Infection 17, 484–486.
23.Mackie, FP (1907) The part played by Pediculus corporis in the transmission of relapsing fever. British Medical Journal 2, 1706–1709.
24.Sparrow, H (1958) Étude du foyer Éthiopien de fièvre récurrente. Bulletin de l'organisation. mondiale de la Santé 19, 673–710.
25.ProMED-mail (International Society for Infectious Diseases). Borreliosis, relapsing fever – Sudan (South). ProMED-mail 1999; 19990511.0767; http://www.promedmail.org. Accessed 27 Oct 2018.
26.Valdizan, M, Lopez, J and Delgado, A (1985) Borreliosis en las alturas del Peru. Diagnóstico (Peru) 15, 9–13.
27.Raoult, D et al. (1999) Survey of three bacterial louse-associated diseases among rural Andean communities in Peru: prevalence of epidemic typhus, trench fever, and relapsing fever. Clinical Infectious Diseases 29, 434–436.
28.Ciervo, A et al. (2016) Louseborne relapsing fever in young migrants, Sicily, Italy, July-September 2015. Emerging Infectious Diseases 22, 152–153.
29.Hoch, M et al. (2015) Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015. Eurosurveillance 20(42), 1–5.
31.Antinori, S et al. (2016) Louse-borne relapsing fever among East African refugees in Europe. Travel Medicine and Infectious Diseases 14, 513–514.
32.Hytönen, J et al. (2017) Louse-borne relapsing fever in Finland in two asylum seekers from Somalia. APMIS Acta Pathologica, Microbiologica, et Immunologica Scandinavica 125, 59–62.
33.Ackermann, N et al. (2018) Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Eurosurveillance 23, 1–11.
34.Isenring, E et al. (2018) Infectious disease profiles of Syrian and Eritrean migrants presenting in Europe: a systematic review. Travel Medicine and Infectious Diseases 25, 65–76.
35.Grecchi, C et al. (2017) Louse-borne relapsing fever in a refugee from Mali. Infection 45, 373–376.
36.Barbour, AG and Hayes, SF (1986) Biology of Borrelia species. Microbiological Reviews 50, 381–400.
37.Vidal, V et al. (1998) Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nature Medicine 4, 1416–1420.
38.Grosskinsky, S et al. (2010) Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Neglected Tropical Diseases 4, e698.
39.Guo, BP et al. (2009) Relapsing fever Borrelia binds to neolacto glycans and mediates rosetting of human erythrocytes. Proceedings of the National Academy of Sciences U S A 106, 19280–19285.
40.Negussie, Y et al. (1992) Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch–Herxheimer reaction of relapsing fever. Journal of Experimental Medicine 175, 1207–1212.
41.Coxon, RE et al. (1997) The effect of antibody against TNF alpha on cytokine response in Jarisch–Herxheimer reactions of louse-borne relapsing fever. Quarterly Journal of Medicine 90, 213–221.
42.Butler, T (2017) The Jarisch–Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis. American Journal of Tropical Medicine and Hygiene 96, 46–52.
43.Warrell, DA et al. (1970) Cardiorespiratory disturbances associated with infective fever in man: studies of Ethiopian louse-borne relapsing fever. Clinical Science 39, 123–145.
44.Judge, DM et al. (1974) D Louse-borne relapsing fever in man. Archives of Pathology 97, 136–170.
45.Anderson, TR and Zimmerman, LE (1955) Relapsing fever in Korea; a clinicopathologic study of eleven fatal cases with special attention to association with Salmonella infections. American Journal of Pathology 31, 1083–1109.
46.Salih, SY et al. (1977) Louse-borne relapsing fever: I. A clinical and laboratory study of 363 cases in the Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 43–48.
47.Perine, PL et al. (1992) A clinico-epidemiological study of epidemic typhus in Africa. Clinical Infectious Diseases 14, 1149–1158.
48.Antinori, S et al. (2017) Diagnosis of Louse-Borne relapsing fever despite negative microscopy in two asylum seekers from Eastern Africa. American Journal of Tropical Medicine and Hygiene 97, 1669–1672.
49.Ramos, JM et al. (2004) Characteristics of louse-borne relapsing fever in Ethiopian children and adults. Annals of Tropical Medicine and Parasitology 98, 191–196.
50.Ramos, JM et al. (2009) Louse-borne relapsing fever in Ethiopian children: experience of a rural hospital. Tropical Doctor 39, 34–36.
51.Borgnolo, G et al. (1993) Louse-borne relapsing fever in Ethiopian children: a clinical study. Annals of Tropical Paediatrics 13, 165–171.
52.Nordmann, T et al. (2018) Outbreak of louse-borne relapsing fever among urban dwellers in Arsi zone, central Ethiopia, from July to November 2016. American Journal of Tropical Medicine and Hygiene 98, 1599–1602.
53.Parry, EH et al. (1970) Some effects of louse-borne relapsing fever on the function of the heart. American Journal of Medicine 49, 472–479.
54.Hovette, P et al. (2001) Value of Quantitative Buffy Coat (QBC) in borreliasis-malaria co-infection. Médecine Tropicale (Marseille) 61, 196–197.
55.Larsson, C and Bergström, S (2008) A novel and simple method for laboratory diagnosis of relapsing fever borreliosis. Open Microbiology Journal 2, 10–12.
56.Berger, SA and David, L (2005) Pseudo-borreliosis in patients with malaria. American Journal of Tropical Medicine and Hygiene 73, 207–209.
57.Elbir, H et al. (2013) Multiplex real-time PCR diagnostic of relapsing fevers in Africa. PLoS Neglected Tropical Diseases 7, e2042.
58.Sokhna, C et al. (2013) Point-of-care laboratory of pathogen diagnosis in rural Senegal. PLoS Neglected Tropical Diseases 7, e1999.
59.Porcella, S et al. (2000) Sero-diagnosis of louse-borne relapsing fever with glycerol phosphodiesterase (GlpQ) from Borrelia recurrentis. Journal of Clinical Microbiology 38, 3561–3571.
60.Fotso Fotso, A et al. (2016) Monoclonal antibodies for the diagnosis of Borrelia crocidurae. American Journal of Tropical Medicine and Hygiene 94, 61–67.
61.Cutuli, SL et al. (2017) Lice, rodents, and many hopes: a rare disease in a young refugee. Critical Care 21, 81.
62.Perine, PL and Teklu, B (1983) Antibiotic treatment of louse-borne relapsing fever in Ethiopia: a report of 377 cases. American Journal of Tropical Medicine and Hygiene 32, 1096–2000.
63.Warrell, DA et al. (1983) Pathophysiology and immunology of the Jarisch–Herxheimer-like reaction in louse-borne relapsing fever: comparison of tetracycline and slow-release penicillin. Journal of Infectious Diseases 147, 898–909.
64.Seboxa, T and Rahlenbeck, S (1995) Treatment of louse-borne relapsing fever with low dose penicillin or tetracycline: a clinical trial. Scandinavian Journal of Infectious Diseases 27, 29–31.
65.Salih, SY and Mustafa, D (1977) Louse-borne relapsing fever: II. Combined penicillin and tetracycline therapy in 160 Sudanese patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 49–51.
66.Warrell, DA (1969) Respiratory, Circulatory and Metabolic Disturbances in Relapsing Fever (Dissertation). Oxford, UK: University of Oxford, 246 pp.
67.Remick, DG et al. (1996) Pentoxifylline fails to prevent the Jarisch–Herxheimer reaction or associated cytokine release. Journal of Infectious Diseases 174, 627–630.
68.Teklu, B et al. (1983) Meptazinol diminishes the Jarisch–Herxheimer reaction of relapsing fever. Lancet 1, 835–839.
69.Wright, DJ (1983) Endogenous opioid withdrawal in the Jarisch–Herxheimer reaction. Lancet 1, 1135–1136.
70.Fekade, D et al. (1996) Prevention of Jarisch–Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. New England Journal of Medicine 335, 311–315.
71.Cooper, PJ et al. (2000) Recombinant human interleukin-10 fails to alter proinflammatory cytokine production or physiologic changes associated with the Jarisch–Herxheimer reaction. Journal of Infectious Diseases 181, 203–209.
72.Parry, EH, Bryceson, AD and Leithead, CS (1967) Acute hemodynamic changes during treatment of louse-borne relapsing fever. Lancet 1, 81–83.
73.Barker, SC and Barker, D (2019) Killing clothes lice by holding infested clothes away from hosts for 10 days to control louseborne relapsing fever, Bahir Dah, Ethiopia. Emerging Infectious Diseases 25, 304–310.